Table 2 Overview of mean peak SCS and mean T2P-SCS measured with CMR-FT endo , tissue tagging and CMR-FT mid
Total study group (n = 30) | Healthy volunteers (n = 10) | LBBB (n = 10) | HCM (n = 10) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMR-FT endo (%) | Tissue tagging (%) | CMR-FT mid (%) | CMR-FT endo (%) | Tissue tagging (%) | CMR-FT mid (%) | CMR-FT endo (%) | Tissue tagging (%) | CMR-FT mid (%) | CMR-FT endo (%) | Tissue tagging (%) | CMR-FT mid (%) | |
Mean peak SCS | -23.8 ± 9.9† | -13.4 ± 3.3 | -16.4 ± 6.1¥$ | -25.9 ± 3.3# | -16.5 ± 1.6 | -20.0 ± 3.1*^ | -12.4 ± 5.6 | -9.9 ± 1.1 | -9.4 ± 3.6^ | -33.2 ± 5.0# | -13.8 ± 2.5 | -19.8 ± 3.9#^ |
Mean T2P-SCS | 380 ± 58 | 378 ± 52 | 390 ± 68 | 336 ± 34* | 354 ± 34 | 330 ± 27* | 418 ± 66* | 376 ± 55 | 454 ± 60* | 388 ± 41 | 405 ± 54 | 384 ± 45 |